News

SHINE 2Europe partner in a new Horizon project that will involve 720 patients with liver cancer

Liver cancer is the fifth most frequent worldwide and the second most deadly, with about 750,000 cases per year. In addition, liver cancer has a high chance of recurrence, even after surgery. The prevalence of local recurrence after resection of hepatocellular carcinoma is 20% or more. But is it possible that an additional innovative technique …

SHINE 2Europe partner in a new Horizon project that will involve 720 patients with liver cancer Read More »

SHINE 2Europe is a partner in the new project for personalized risk assessment for heart failure.

AI4HF is a new project funded by Horizon Europe, that brings together 16 partners from Europe, Peru and Tanzania, aiming to design, develop, evaluate and explore a reliable Artificial Intelligence solution for personalized assessment of the risk of heart failure. Leading the project is the Netherlands Heart Institute and Portugal is represented in the partnership …

SHINE 2Europe is a partner in the new project for personalized risk assessment for heart failure. Read More »

Scroll to Top